Skip to search boxSkip to navigationSkip to main content

Spinal cord astrocytoma: Response to PCV chemotherapy

  • John W. Henson(corresponding author)
    ,
  • Allan F. Thornton
    ,
  • David N. Louis
*Corresponding author for this work
  • Harvard University
    ,
  • Cox 315
Scholary Output:
Contribution to journal
Article
 Peer-review

Abstract

Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 518-520 (3 pages)

Journal (Volume, Issue Number)

Neurology (Volume 54, Issue 2)

Publication milestones

  • Published - 01/25/2000

Publication status

Published - 01/25/2000

ISSN

0028-3878

Publication IDs

  • Scopus: 0034711671
  • PubMed: 10668731

Access to documents

Publication metrics

Metrics

Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
0.39
SciVal
Author count
3
SciVal
Paper percentile
64
SciVal
citations
16
Scopus
citations
24, opens in new tab

PlumX, opens in new tab

Citation count
24
Captures
8